Clopidogrel bisulfate modulates metabolic activity and ERK-associated signaling in human endothelial progenitor cells under oxidative stress: an in vitro study
Seoho Jahng, Mijung Lee, Manho Kim · 2026
Read Clopidogrel bisulfate modulates metabolic activity and ERK-associated signaling in human endothelial progenitor cells under oxidative stress: an in vitro study by Seoho Jahng, Mijung Lee, Manho Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13333998.txt.
Description
Seoho Jahng, Mijung Lee, and Manho Kim wrote a study from 2026 on how a common heart drug acts on repair cells in blood vessel walls. The drug, named clopidogrel, is used to stop blood clots. Repair cells drawn from blood help heal vessel lining and grow new vessels. Whether the drug acts on those cells in their own right was not known. The team grew the cells from human blood in the lab.
Dosed cells kept their shape, packed more densely, and showed no rise in cell death. A test of cell work showed more activity over time. At rest, key death and growth signals barely moved. Under harsh oxygen stress, the drug shifted two death-linked proteins toward life and raised a growth signal. The team reads this as a stress-only help that may aid vessel repair.
Catalog record
| CREATOR | Seoho Jahng, Mijung Lee, Manho Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |